Navigation Links
Perceptum Group Announces New Situational Leadership V Series

Company expands its management development service offering with the addition of Situational Leadership V™ series to its portfolio.

San Francisco, Calif. (PRWEB) October 2, 2009 -- Perceptum Group, LLC announced today the introduction of its new Situational Leadership V (SLV) series specifically for biotech and specialty pharma companies. The new series includes Situational Leadership V™, Situational Self Leadership and Advanced Situational Leadership V™.

In Situational Leadership V the Perceptum Group expands upon Hersey and Blanchard's models to now include five developmental levels and leadership styles. Participants are taught to use emotional intelligence concepts, conflict management techniques, and effective communication strategies to facilitate application of situational leadership. Situational Self Leadership teaches life sciences sales representatives, whose time is primarily spent in the field by themselves, on how to acquire the ability to be "self leaders." Advanced Situational Leadership V provides sales managers practical leadership tools they can use to accelerate a sales representative's development from enthusiastic beginner to peak performer.

Perceptum customizes each SLV program to the specific products, market space and sales culture of its biotech and specialty pharma clients. "Delivering programs that are relevant to our life sciences clients by utilizing client-specific, field-based situations greatly enhances the value and effectiveness in achieving desired short and long-term behaviors" said Don Wright, Perceptum's Vice President of Business Development. "The SLV series will provide life sciences companies a common leadership framework throughout their entire organization."

To learn more about Perceptum's Situational Leadership V, go to:    


About Perceptum Group

The Perceptum Group is the leading training, education and development company for the life sciences industry. Biotechnology, specialty pharmaceutical, and medical device companies seeking to expand and develop their markets rely on the Perceptum Group for sales and physician training as well as development of their sales management professionals. Perceptum catalyzes insights for a company's sales organization, builds their capabilities, mobilizes them to act and helps execute in the field to drive measurable results. The Perceptum Group is a privately held consulting firm headquartered in San Francisco, California providing services in the U.S., EU and Latin America. For more information please visit or call 415.495.3331.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Avicena Group to Present at Noble Financial Conference
2. Chrome Group to Seek Listing for Some of its Subsidiaries
3. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
4. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. ThirdBiotech Networking Group Launches
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
11. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
Post Your Comments:
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... business and prospects remain fundamentally strong and highlights ... doxorubicin) recently received DSMB recommendation to continue the ... review of the final interim efficacy and safety ... Endpoint in men with heavily pretreated castration- and ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
Breaking Biology Technology:
(Date:11/4/2015)... , November 4, 2015 ... new market report published by Transparency Market Research "Home Security ... Trends and Forecast 2015 - 2022", the global home security ... 30.3 bn by 2022. The market is estimated to ... period from 2015 to 2022. Rising security needs among ...
(Date:10/29/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that it has been selected ... of only three finalists for a 2015 Tekne ... category. The Tekne Awards honor Minnesota ... and leadership. iMedNet™ eClinical  technology ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a ... that it has released a new version of its ... in North America have already ... v4.0 also includes a FIDO UAF certified server ... already preparing to activate FIDO features. These customers include ...
Breaking Biology News(10 mins):